Investing

Fennec Pharmaceuticals : FENC

FENC

Stock Data

$6.54

$0.05 (0.77%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Fennec Pharmaceuticals Inc., originally known as Adherex Technologies Inc. until 2014, is a biopharmaceutical company focused on addressing a specific healthcare challenge in pediatric cancer treatment. It develops PEDMARK, a unique formulation aimed at preventing hearing loss caused by platinum-based chemotherapy in children with cancer. Based in Research Triangle Park, North Carolina, since its inception in 1996, Fennec makes its innovative treatments available through specialized pediatric oncology networks.

All Fennec Pharmaceuticals Articles

1 Article

Lee Jackson | Feb 12, 2026 at 8:00 AM EST

Here Are Thursday’s Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More

Pre-Market Stock Futures: Futures are trading higher after a wild Wednesday that saw the market rally hard on the open…